Subarachnoid haemorrhage (SAH) causes early brain injury (EBI) that is mediated by effects
of transient cerebral ischaemia during bleeding plus effects of the subarachnoid blood …

Rupture of an intracranial aneurysm is the leading cause of subarachnoid hemorrhage not
due to trauma. This review summarizes both the approach to establishing the diagnosis and …

Cerebral vasospasm has traditionally been regarded as an important cause of delayed
cerebral ischaemia (DCI) which occurs after aneurysmal subarachnoid haemorrhage, and …

Objective To report the ESICM consensus and clinical practice recommendations on fluid
therapy in neurointensive care patients. Design A consensus committee comprising 22 …

Cerebral vasospasm is a prolonged but reversible narrowing of cerebral arteries beginning
days after subarachnoid hemorrhage. Progression to cerebral ischemia is tied mostly to …

Background: The optimal resuscitative fluid remains controversial. Objective: To assess the
association between crystalloid fluid and outcomes in critically ill adults. Methods …

Vasospasm is one of the leading causes of morbidity and mortality following aneurysmal
subarachnoid hemorrhage (SAH). Radiographic vasospasm usually develops between 5 …

The management of patients with aneurysmal subarachnoid haemorrhage demands
expertise to anticipate, recognise, and promptly treat the many neurological and systemic …

Human serum albumin (HSA) is a non-glycosylated, negatively charged, single-chain
polypeptide composed of 585 amino acid residues with a relative molecular mass of 66.438 …

BACKGROUND: Delayed vasospasm is the leading cause of morbidity and mortality after
aneurysmal subarachnoid hemorrhage (aSAH). This phenomenon was first described more …